AlphAIAlphAI — Financial news for AI agents
SEC EDGAR$BFLY

DEVIVO JOSEPH sold $359K of BFLY

DEVIVO JOSEPH (President & CEO) sold 35,790 shares of Butterfly Network, Inc. (BFLY) at $10.02 ($0.36M total) on 2026-10-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · DEVIVO JOSEPH
Published Oct 8, 2026, 9:55 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 9:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$BFLY
Bearish
medium confidence
Mentioned
$BFLY
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BFLYBearishLow
01

Why it matters

The disclosed sale reduces the CEO's holdings to 7.3 million shares, a modest decrease that may affect perception.

02

Market read

The filing provides fresh insider activity data, offering a small but actionable insight for traders.

03

What to watch

The 10b5-1 plan pre‑arranged sale may have been scheduled before any material news.

Relevance 3/10Novelty 3/10Timing: after-hours filing

Background

Form 4 filings disclose insider transactions; a CEO sale is noteworthy for investors.

Company-level read

Ticker impact

$BFLYBearishMedium confidence
Context

President & CEO Devivo Joseph sold 35,790 shares for $358,615.80 via a 10b5-1 plan, reducing his stake.

Expected impact

likely pressure as the market prices in the insider sell

Evidence & confidence

The sale is modest but involves the CEO, which can be interpreted as a negative signal.

Market effects

Sector

Minimal impact on the medical imaging sector; the sale is company‑specific.

Regional

No broader regional effect.

Global

Limited to investors tracking insider activity.

Counterpoint

What could challenge this read

The sale could be routine liquidity for personal reasons, not a negative signal.

Key entities

  • Company
    Butterfly Network, Inc.

    Medical imaging device maker listed on NASDAQ under BFLY.

  • Executive
    Devivo Joseph

    President & CEO of Butterfly Network.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

BFLY insider trading history →

Related articles

$BFLYHigh

Butterfly Network Q3 Earnings Call Highlights

Butterfly Network (BFLY) reported Q3 record gross profit of $23.8M, up from a $3.8M loss last year. Adjusted EBITDA loss narrowed to $1.2M. Full-year 2026 revenue guidance raised to $123M-$126M. Company plans international strategy shift and expects FedRAMP authorization to boost government business. Cash reserves at $122M.

finance.yahoo.com
$BFLYMed

Butterfly (BFLY) Q3 2026 Earnings Call Transcript

Butterfly (BFLY) reported Q3 2026 revenue of $32.6M, beating guidance by 9%. The company raised full-year guidance and highlighted growth in U.S. enterprise contracts and international expansion. Key developments include FedRAMP authorization for federal government contracts and new partnerships in brain-computer interface and healthcare applications.

finance.yahoo.com
$BFLYMed

Butterfly Network, Inc. Q3 2026 Earnings Call Summary

Butterfly Network reported Q3 2026 earnings, highlighting revenue growth driven by its Embedded business and U.S. enterprise contracts. International performance lagged, but the company is shifting to an institutional model. Gross margins reached 73%, and full-year guidance was raised. The company plans to launch new chips and enter the cart-based ultrasound market by 2028. A $150M ATM program was established for financial flexibility.

finance.yahoo.com
$BFLYMed

Butterfly Network Reports Third Quarter 2026 Financial Results

Butterfly Network, Inc. (BFLY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Butterfly Network Reports Third Quarter 2026 Financial Results Beats High End of Quarterly Revenue and Adjusted EBITDA Guidance • Delivered quarterly Revenue of $32.6 million, driven in part by Embedded revenue • Recorded highest gross margin in Company history at 73

SEC EDGAR 8-K
$QSIMed

2 Brain-Computer Interface Stocks to Watch While Neuralink Stays Private

Neuralink, a private brain-computer interface (BCI) company, successfully helped a patient with ALS communicate. Investors cannot buy Neuralink, but two public companies, Quantum-Si (QSI) and Butterfly Network (BFLY), are connected to the BCI field. QSI makes research tools and saw a 7x volume spike, while BFLY supplies ultrasound chips to BCI developers like Merge Labs and Bridge Neurotech.

investorplace.com
$BFLYHigh

Why is Butterfly Network stock climbing today?

Butterfly Network (BFLY) stock rose 1.6% pre-market after Canaccord Genuity initiated coverage with a Buy rating and $10 target, citing its ultrasound tech and AI capabilities. Analysts highlight new products and partnerships. The stock has seen positive analyst activity, with a consensus target of $11.40. Q3 earnings are due October 29.

investing.com